New Delhi: The number of cervical cancer is increasing day by day. To control it, Serum Institute has developed the country’s first uterine cancer vaccine. The name of the vaccine is Quadrivalent Human Papilloma Virus (HPV) Vaccine. In the first phase, this vaccine will be given to girls aged 10 to 14 years.
Serum Institute CEO Adar Poonawala informed about the preparation of the vaccine. Its prices will be decided very soon, Poonawala said. He said that the vaccine price will be around 200 to 400. According to him, the rates will be finalized after discussions with the central government.
However, every 8 minutes in the country, a woman dies only because of this cervical cancer. The vaccine can be termed helpful in such a situation. India ranks 5th in the world in the number of cervical cancer. There is a plan to give the HPV vaccine to girls in high schools in 10 districts of the state. Under the National Health Mission 2022-24, an amount of Rs. 10 crores has been approved for this group of vaccines. There is information that two vaccines should be taken. The second dose should be taken 6 to 12 months after the first dose.